Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Spectacular Images Showing Research into Cancer, Neurodegenerative Disease and Fertility

Published: Wednesday, March 12, 2014
Last Updated: Wednesday, March 12, 2014
Bookmark and Share
Vanessa Auld from Canada, Martin Barr from Ireland and Graham Wright from Singapore announced as the winners of the GE Healthcare 2013 Cell Imaging Competition.

With over 23,000 votes cast by the public, the winners can now look forward to seeing their prize-winning images lighting up Times Square, New York at a special event between 25-27 April 2014.

For seven years, GE Healthcare’s annual competition has showcased the beauty of cells and the inspiring research of cellular biologists from around the world.   This year’s competition attracted over 100 entries from scientists who are using either high-content analysis or high- and super resolution microscopy to investigate at the cellular level a wide variety of diseases such as cancer, muscle disease and the effects of parasitic infections.

An expert scientific panel of six judges* shortlisted the finalists for each category ahead of the public vote. The full details of the three winners are:

1st place - Microscopy category

1stplace_microscopy.gif

Vanessa Auld, University of British Columbia, Vancouver, Canada.

Image description: Drosophila neuromuscular junction stained for extracellular matrix proteins (green and blue) and the nerve terminal (red).

Therapeutic focus: Neurodegenerative disease.

1st place – High-Content Analysis category

1stplace_HCA.gif

Martin Barr, St James’s Hospital and Trinity College Dublin, Dublin, Ireland.

Image description: Lung adenocarcinoma cell stained for F-actin (green), mitochondria (red) and DNA (blue).

Therapeutic focus: Cancer.

Regional winner (Microscopy category)

Regionalwinner_microscopy.gif

Graham Wright, Institute of Medical Biology, A*STAR, Singapore

Image description: Mouse spermatocyte spread stained for KASH-5 and SCP3 (red and green) and DNA (blue).

Therapeutic focus: Fertility.

Eric Roman, General Manager of Research and Applied Markets, GE Healthcare Life Sciences, said:

“This year’s three winning images are once again incredibly beautiful and compelling, reminding us of the cellular complexity behind disease and why the study of cells is so important.  We were delighted to receive so many outstanding entries to the competition, which highlights how cell imaging is helping scientists explore the universe of the cell and is advancing our understanding of so many life-threatening and life-limiting diseases. I’d like to thank all the contestants for sending us their images, the judging panel and everyone who cast a vote.”

The winning images and gallery of all the finalists’ entries to the 2013 Cell Imaging Competition are available at www.gelifesciences.com/cellimagecompetition

*This year’s shortlist was selected by Paul Goodwin, Science Director, Cellular Imaging and Analysis at GE Healthcare; Geoffrey Grandjean, Sanford Burnham Medical Research Institute, California and 2011 competition winner for the Americas; Julian P. Heath, Editor of Microscopy & Analysis; Carmen Laethem, Scientist and Project Manager, Aerie Pharmaceuticals; Kristie Nybo, Assistant Editor, BioTechniques and Nick Thomas, Principal Scientist at GE Healthcare.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

GE Healthcare Life Sciences to Create New US Headquarters
When fully operational, the new facility will house more than 500 highly skilled employees and bring more than 220 new jobs to Massachusetts.
Wednesday, August 20, 2014
Scientific News
New Cancer Drug Target in Dual-Function Protein
Scientists at The Scripps Research Institute (TSRI) have identified a protein that launches cancer growth and appears to contribute to higher mortality in breast cancer patients.
Penn State, TB Alliance, and GSK Partner To Discover New Treatments For TB
A new collaboration between TB Alliance, GSK, and scientists in the Eberly College of Science seeks to find new small molecules that can be used to create antibiotics in the fight against tuberculosis (TB).
Molecular Map Provides Clues To Zinc-Related Diseases
Mapping the molecular structure where medicine goes to work is a crucial step toward drug discovery against deadly diseases.
Platelets are the Pathfinders for Leukocyte Extravasation During Inflammation
Findings from the study could help in the prevention and treatment of inflammatory pathologies.
Genetic Research Can Significantly Improve Drug Development
With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars?
New Method Opens Door to Development of Many New Medicines
Findings from TSRI reveal human proteins are better drug targets than previously thought.
Diagnosing Systemic Infections Quickly, Reliably
Team develop rapid and specific diagnostic assay that could help physicians decide within an hour whether a patient has a systemic infection and should be hospitalized for aggressive intervention therapy.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Blood Test That Detects Early Alzheimer’s Disease
A research team, led by Dr. Robert Nagele from Rowan University School of Osteopathic Medicine and Durin Technologies, Inc., has announced the development of a blood test that leverages the body’s immune response system to detect an early stage of Alzheimer’s disease – referred to as the mild cognitive impairment (MCI) stage – with unparalleled accuracy.
A New Approach to Chemical Synthesis
Communesins, originally found in fungus, could hold potential as cancer drugs.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!